Acting Governor Donald DiFrancesco of the US state of New Jersey hassigned into law an expansion of the state's prescription drug aid program for about 100,000 middle-income disabled people and seniors, a benefit which was previously limited to low-income residents.
The Senior Gold plan offers help to couples on incomes up to $33,589 and singles earning up to $29,238. They will be charged a higher co-payment than low-income residents, at $15 plus half the cost of the prescription or the medication's cost, whichever is cheaper. It provides full catastrophic care cover once individual enrollees have paid $2,000 a year in prescription costs, or $3,000 for couples. In all cases, beneficiaries still pay $15 for each prescription under the catastrophic plan, but the state assumes the full cost of the balance.
The new program will be paid for with the $7.6 billion that the state expects to receive over the next 25 years from the national tobacco settlement.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze